FAR Publishing Limited Jun 25 2026 Reviewed A study published in  Current Molecular Pharmacology  provides a comprehensive analysis of microRNA-29a (miR-29a) as a pivotal regulator in cancer development, and examines how natural bioactive compounds may offer a promising strategy for cancer prevention by modulating its expression. The article, authored by Muhanad Alhujaily from Imam Mohammad Ibn Saud Islamic University, details how miR-29a functions either as a tumor suppressor or an oncogene

Tag-uri: Islam